Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - OTHER CURRENT ASSETS
Other Current Assets IKT - Inhibikase Therapeutics, Inc.
959 K
LAST VALUE
-22.82%
2 YEAR CAGR
19.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR